Cytokinetics, Incorporated
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
BLUM ROBERT I director, officer: President & ..
Common Stock 5,000 $8.47 $42,350
Sale
SABRY JAMES H other: Former Executive Chairman
Common Stock 2,000 $8.5 $17,000
Option
BLUM ROBERT I director, officer: President & ..
Common Stock 5,000 $6.24 $31,185
Option
BLUM ROBERT I director, officer: President & ..
Non-Qualified Stock Option (right to buy) 7,400 $4.98 $36,837
Sale
SABRY JAMES H other: Former Executive Chairman
Common Stock 6,000 $8.7 $52,200
Sale
BLUM ROBERT I director, officer: President & ..
Common Stock 2,500 $1.2 $3,000
Sale
MORGANS DAVID J JR officer: EVP-Preclinical R&D
Common Stock 22,500 $7.92 $178,290
Sale
TRAUTMAN JAY K officer: VP, Discovery Research
Common Stock 32,000 $7.41 $237,248
Sale
MORGANS DAVID J JR officer: EVP-Preclinical R&D
Common Stock 12,500 $7.45 $93,138
Sale
BLUM ROBERT I director, officer: President & ..
Common Stock 5,000 $9.67 $48,325
Sale
BLUM ROBERT I director, officer: President & ..
Common Stock 5,000 $9.25 $46,250
Sale
BLUM ROBERT I director, officer: President & ..
Common Stock 10,000 $9.5 $95,000
Sale
HEIDRICH A GRANT III director
Common Stock 15,400 $8.8 $135,535
Sale
HEIDRICH A GRANT III director
Common Stock 10,000 $8.72 $87,240
Sale
HEIDRICH A GRANT III director
Common Stock 74,600 $8.56 $638,427
Purchase
DOW STEPHEN M director
Common Stock 20,000 $9 $179,920
Purchase
DOW STEPHEN M director
Common Stock 40,000 $8.33 $333,040

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.